Excellence in Dermatology™
Excellence in Dermatologic Surgery™
Excellence in Medical Dermatology™
Excellence in Dermatopathology™

Return to program book search

Session Information

FRM F082 - Dermatologic Manifestations of New Oncology Drugs

Open admission to eligible categories, no tuition or ticket


Date: Sunday, March 03

CME Credits: 2.00

Location: Palm Ballroom 4

Time: 1:00 PM - 3:00 PM

Director: Mario E. Lacouture, MD, FAAD


  • Milan J. Anadkat, MD, FAAD
  • Jennifer N. Choi, MD, FAAD
  • Beth McLellan, MD, FAAD
  • Patricia L. Myskowski, MD, FAAD

Learning Objectives:
Following this course, the attendee should be able to:

  • Summarize skin, hair, and nail reactions to new chemotherapies in cancer.
  • Analyze mechanisms underlying dermatologic reactions to new chemotherapies in cancer.
  • Treat dermatologic reactions to new chemotherapies in cancer.

The increased approval of anticancer agents has led to improved quality of life and longer survival times, resulting in millions of individuals living with cancer. Whereas novel drugs are responsible for these achievements, an unexpected constellation of side effects has emerged. Most notably, cutaneous toxicities are notable due to their high frequency, relative effectiveness of anti-skin toxicity interventions, and the otherwise decreasing incidence of systemic or hematopoietic adverse events. This session provides a basis for the understanding and management of dermatologic side effects in the oncology setting, in order to promote attentive care to cutaneous health in cancer patients.


Sunday, March 03
1:00 PMIntroduction to New Oncology Drugs / Dr. Lacouture
1:05 PMDermatologic Adverse Events to New Cytotoxic Chemotherapies / Dr. Anadkat
1:25 PMDermatologic Adverse Events to Targeted Therapies / Dr. Lacouture
1:50 PMGetting a Grip on Hand Foot Syndrome / Dr. McLellan
2:10 PMAdverse Events to Topical Anticancer Therapies / Dr. Myskowski
2:30 PMRadiation Therapy Induced Toxicities / Dr. Choi
2:50 PMPanel Discussion / All faculty